Discover
GILD
Gilead Sciences, Inc.
150.11
2 x 149.99
1 x 158.37
bid
ask
-
0.78
0.52%
2 @ 07:30 PM
151.50 +1.39 (0.93%)
| Ytd | 22.30% | |
| 1y | 32.12% |
149.57
day range
153.23
110.56
52 week range
155.80
| Open | 150.66 | Prev Close | 150.89 | Low | 149.57 | High | 153.23 | Mkt Cap | 186.13B |
| Vol | 16.42M | Avg Vol | 6.76M | EPS | -2.66 | P/E | N/A | Forward P/E | 15.18 |
| Beta | 0.35 | Short Ratio | 3.62 | Inst. Own | 92.21% | Dividend | 3.28 | Div Yield | 2.17 |
| Ex Div Date | 09-15 | Earning | 10-29 | 50-d Avg | 139.56 | 200-d Avg | 135.29 | 1yr Est | 158.15 |
| Income Statement | |||
| Total Revenue | 7.80B | ||
| Revenues (USD) | 7.80B | ||
| Cost of Revenue | 1.58B | ||
| Gross Profit | 6.22B | ||
| Operating Expenses | 16.62B | ||
| Research and Development Expense | 1.76B | ||
| Selling, General and Administrative Expense | 1.92B | ||
| Operating Income | -10.39B | ||
| Interest Expense | 247.00M | ||
| Income Tax Expense | 242.00M | ||
| Net Income | -10.50B | ||
| Net Income Common Stock | -10.50B | ||
| Net Income Common Stock (USD) | -10.50B | ||
| Consolidated Income | -10.50B | ||
| Earnings per Basic Share | -8.45 | ||
| Earnings per Basic Share (USD) | -8.45 | ||
| Earnings per Diluted Share | -8.45 | ||
| Dividends per Basic Common Share | 0.82 | ||
| Earning Before Interest & Taxes (EBIT) | -10.01B | ||
| Earning Before Interest & Taxes (USD) | -10.01B | ||
| Weighted Average Shares | 1.24B | ||
| Weighted Average Shares Diluted | 1.24B | ||
| Balance Sheet | |||
| Cash and Equivalents | 3.18B | ||
| Cash and Equivalents (USD) | 3.18B | ||
| Trade and Non-Trade Receivables | 5.06B | ||
| Current Assets | 13.95B | ||
| Property, Plant & Equipment Net | 5.83B | ||
| Total Assets | 49.36B | ||
| Debt Current | 2.41B | ||
| Total Debt | 26.25B | ||
| Current Liabilities | 11.02B | ||
| Debt Non-Current | 23.83B | ||
| Total Liabilities | 37.62B | ||
| Accumulated Retained Earnings (Deficit) | 2.20B | ||
| Accumulated Other Comprehensive Income | 95.00M | ||
| Shareholders Equity | 11.83B | ||
| Shareholders Equity (USD) | 11.83B | ||
| Assets Non-Current | 35.42B | ||
| Total Debt (USD) | 26.25B | ||
| Goodwill and Intangible Assets | 22.35B | ||
| Inventory | 1.95B | ||
| Liabilities Non-Current | 26.60B | ||
| Trade and Non-Trade Payables | 674.00M | ||
| Tax Assets | 2.49B | ||
| Tax Liabilities | 1.28B | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 698.00M | ||
| Net Cash Flow from Financing | 2.34B | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -4.45B | ||
| Capital Expenditure | -140.00M | ||
| Net Cash Flow - Business Acquisitions and Disposals | -11.21B | ||
| Issuance (Purchase) of Equity Shares | -346.00M | ||
| Issuance (Repayment) of Debt Securities | 4.07B | ||
| Payment of Dividends & Other Cash Distributions | -1.03B | ||
| Net Cash Flow from Investing | -10.35B | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 983.00M | ||
| Net Cash Flow from Operations | 3.57B | ||
| Effect of Exchange Rate Changes on Cash | -19.00M | ||
| Share Based Compensation | 231.00M | ||